SG/CALL/MERCK/225/0.1/19.12.25 Share Price

Warrant

DE000SU9B640

Real-time Boerse Frankfurt Warrants 10:09:28 13/05/2024 BST
0.54 EUR +3.85% Intraday chart for SG/CALL/MERCK/225/0.1/19.12.25
Current month+13.04%
1 month+6.12%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change Volume
13/05/24 0.54 +3.85% 0
10/05/24 0.52 -1.89% 0
09/05/24 0.53 +3.92% 0
08/05/24 0.51 0.00% 0
07/05/24 0.51 +6.25% 0

Real-time Boerse Frankfurt Warrants

Last update May 13, 2024 at 10:09 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK KGAA
IssuerLogo Issuer Société Générale Société Générale
WKN SU9B64
ISINDE000SU9B640
Date issued 14/02/2024
Strike 225
Maturity 19/12/2025 (586 Days)
Parity 10 : 1
Emission price 0.7
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.76
Lowest since issue 0.41
Spread 0.02
Spread %3.57%

Company Profile

Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Sector
-
More about the company

Ratings for Merck KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Merck KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
155.5 EUR
Average target price
179.8 EUR
Spread / Average Target
+15.64%
Consensus